Compare Aurobindo Pharma with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ALEMBIC AUROBINDO PHARMA/
ALEMBIC
 
P/E (TTM) x 7.6 177.5 4.3% View Chart
P/BV x 1.9 1.2 154.3% View Chart
Dividend Yield % 0.6 0.2 309.8%  

Financials

 AUROBINDO PHARMA   ALEMBIC
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
ALEMBIC
Mar-21
AUROBINDO PHARMA/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,023123 833.5%   
Low Rs33332 1,041.7%   
Sales per share (Unadj.) Rs422.82.9 14,768.4%  
Earnings per share (Unadj.) Rs92.00.5 17,063.3%  
Cash flow per share (Unadj.) Rs110.00.7 15,883.5%  
Dividends per share (Unadj.) Rs4.000.20 2,000.0%  
Avg Dividend yield %0.60.3 228.2%  
Book value per share (Unadj.) Rs374.389.5 418.4%  
Shares outstanding (eoy) m585.94256.78 228.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.627.0 5.9%   
Avg P/E ratio x7.4143.5 5.1%  
P/CF ratio (eoy) x6.2111.7 5.5%  
Price / Book Value ratio x1.80.9 209.5%  
Dividend payout %4.337.1 11.7%   
Avg Mkt Cap Rs m397,39819,868 2,000.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35,350226 15,644.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,746735 33,699.6%  
Other income Rs m3,809109 3,488.9%   
Total revenues Rs m251,555844 29,793.4%   
Gross profit Rs m81,480104 78,143.1%  
Depreciation Rs m10,55439 26,786.5%   
Interest Rs m7454 20,577.3%   
Profit before tax Rs m73,990170 43,418.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,09832 62,805.3%   
Profit after tax Rs m53,892138 38,936.3%  
Gross profit margin %32.914.2 231.9%  
Effective tax rate %27.218.8 144.7%   
Net profit margin %21.818.8 115.5%  
BALANCE SHEET DATA
Current assets Rs m198,2351,021 19,416.9%   
Current liabilities Rs m106,652594 17,950.3%   
Net working cap to sales %37.058.1 63.7%  
Current ratio x1.91.7 108.2%  
Inventory Days Days1910,191 0.2%  
Debtors Days Days52686 7.5%  
Net fixed assets Rs m135,77823,069 588.6%   
Share capital Rs m586514 114.1%   
"Free" reserves Rs m218,71322,457 973.9%   
Net worth Rs m219,29922,970 954.7%   
Long term debt Rs m1,6840-   
Total assets Rs m334,01324,090 1,386.5%  
Interest coverage x100.348.1 208.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70 2,430.5%   
Return on assets %16.40.6 2,774.4%  
Return on equity %24.60.6 4,078.3%  
Return on capital %33.80.8 4,463.7%  
Exports to sales %53.81.5 3,647.6%   
Imports to sales %16.46.1 270.4%   
Exports (fob) Rs m133,24811 1,229,223.2%   
Imports (cif) Rs m40,61545 91,125.9%   
Fx inflow Rs m133,24811 1,229,223.2%   
Fx outflow Rs m44,94645 100,842.7%   
Net fx Rs m88,302-34 -261,791.3%   
CASH FLOW
From Operations Rs m33,289-22 -152,562.8%  
From Investments Rs m5,987-347 -1,723.4%  
From Financial Activity Rs m-13,648-154 8,884.3%  
Net Cashflow Rs m25,831-523 -4,940.8%  

Share Holding

Indian Promoters % 48.8 70.9 68.8%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 37.2 6.1 608.3%  
FIIs % 21.7 1.2 1,765.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 29.1 165.4%  
Shareholders   329,940 80,561 409.6%  
Pledged promoter(s) holding % 24.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   GUJ.TERC LAB  DENIS CHEM LAB  ALKEM LABORATORIES  JAGSON PHAR  DECCAN HEALTH CARE  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Oct 22, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - HEMO ORGANIC COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS